Esmirtazapine Uses, Dosage, Side Effects and more

Esmirtazapine, known by the standardized identifier SCH 900265, was under development by Organon to treat insomnia and vasomotor symptoms associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses similar overall pharmacology. This includes inverse agonist activity of H1 and 5-HT2 receptors and antagonism of α2-adrenergic receptors. Merck has terminated its internal clinical development program for esmirtazapine as of March 2010.

Trade Name Esmirtazapine
Generic Esmirtazapine
Esmirtazapine Other Names Esmirtazapine
Type
Formula C17H19N3
Weight Average: 265.36
Monoisotopic: 265.157897624
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in insomnia and sleep disorders.

Half Life

10 hours

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share